nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—OPRD1—coronary artery disease	0.222	1	CbGaD
Fentanyl—Quinapril—Perindopril—coronary artery disease	0.0446	0.156	CrCrCtD
Fentanyl—Quinapril—Trandolapril—coronary artery disease	0.0348	0.122	CrCrCtD
Fentanyl—Quinapril—Enalapril—coronary artery disease	0.0348	0.122	CrCrCtD
Fentanyl—Benazepril—Trandolapril—coronary artery disease	0.0332	0.116	CrCrCtD
Fentanyl—Benazepril—Enalapril—coronary artery disease	0.0332	0.116	CrCrCtD
Fentanyl—Quinapril—Lisinopril—coronary artery disease	0.0272	0.0955	CrCrCtD
Fentanyl—Quinapril—Ramipril—coronary artery disease	0.0264	0.0925	CrCrCtD
Fentanyl—Benazepril—Lisinopril—coronary artery disease	0.0259	0.091	CrCrCtD
Fentanyl—Benazepril—Ramipril—coronary artery disease	0.0251	0.0881	CrCrCtD
Fentanyl—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0157	0.0499	CbGbCtD
Fentanyl—CYP3A7—Eplerenone—coronary artery disease	0.0157	0.0499	CbGbCtD
Fentanyl—ABCB1—Ticagrelor—coronary artery disease	0.0134	0.0424	CbGbCtD
Fentanyl—CYP3A5—Clopidogrel—coronary artery disease	0.0127	0.0403	CbGbCtD
Fentanyl—CYP3A5—Eplerenone—coronary artery disease	0.0118	0.0375	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0101	0.0322	CbGbCtD
Fentanyl—CYP3A7—Simvastatin—coronary artery disease	0.0101	0.0322	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00993	0.0315	CbGbCtD
Fentanyl—CYP3A7—Lovastatin—coronary artery disease	0.00993	0.0315	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00904	0.0287	CbGbCtD
Fentanyl—CYP3A7—Atorvastatin—coronary artery disease	0.00904	0.0287	CbGbCtD
Fentanyl—ABCB1—Clopidogrel—coronary artery disease	0.00827	0.0262	CbGbCtD
Fentanyl—ABCB1—Perindopril—coronary artery disease	0.00827	0.0262	CbGbCtD
Fentanyl—CYP3A5—Rosuvastatin—coronary artery disease	0.00818	0.026	CbGbCtD
Fentanyl—CYP3A4—Ticagrelor—coronary artery disease	0.00802	0.0254	CbGbCtD
Fentanyl—CYP3A5—Simvastatin—coronary artery disease	0.00761	0.0241	CbGbCtD
Fentanyl—CYP3A5—Lovastatin—coronary artery disease	0.00745	0.0236	CbGbCtD
Fentanyl—CYP3A5—Pravastatin—coronary artery disease	0.00745	0.0236	CbGbCtD
Fentanyl—ABCB1—Telmisartan—coronary artery disease	0.00723	0.0229	CbGbCtD
Fentanyl—ABCB1—Pitavastatin—coronary artery disease	0.00723	0.0229	CbGbCtD
Fentanyl—CYP3A4—Fenofibrate—coronary artery disease	0.00715	0.0227	CbGbCtD
Fentanyl—ABCB1—Enalapril—coronary artery disease	0.00685	0.0217	CbGbCtD
Fentanyl—ABCB1—Lisinopril—coronary artery disease	0.00685	0.0217	CbGbCtD
Fentanyl—CYP3A5—Atorvastatin—coronary artery disease	0.00678	0.0215	CbGbCtD
Fentanyl—CYP3A5—Losartan—coronary artery disease	0.0062	0.0197	CbGbCtD
Fentanyl—ABCB1—Timolol—coronary artery disease	0.00582	0.0185	CbGbCtD
Fentanyl—CYP3A4—Gemfibrozil—coronary artery disease	0.00571	0.0181	CbGbCtD
Fentanyl—ABCB1—Ezetimibe—coronary artery disease	0.00533	0.0169	CbGbCtD
Fentanyl—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00519	0.0165	CbGbCtD
Fentanyl—ABCB1—Captopril—coronary artery disease	0.00513	0.0163	CbGbCtD
Fentanyl—CYP3A4—Clopidogrel—coronary artery disease	0.00495	0.0157	CbGbCtD
Fentanyl—ABCB1—Simvastatin—coronary artery disease	0.00495	0.0157	CbGbCtD
Fentanyl—ABCB1—Lovastatin—coronary artery disease	0.00485	0.0154	CbGbCtD
Fentanyl—ABCB1—Pravastatin—coronary artery disease	0.00485	0.0154	CbGbCtD
Fentanyl—CYP3A4—Eplerenone—coronary artery disease	0.0046	0.0146	CbGbCtD
Fentanyl—ABCB1—Atorvastatin—coronary artery disease	0.00441	0.014	CbGbCtD
Fentanyl—CYP3A4—Enalapril—coronary artery disease	0.0041	0.013	CbGbCtD
Fentanyl—ABCB1—Losartan—coronary artery disease	0.00404	0.0128	CbGbCtD
Fentanyl—CYP3A4—Ezetimibe—coronary artery disease	0.00319	0.0101	CbGbCtD
Fentanyl—CYP3A4—Rosuvastatin—coronary artery disease	0.00319	0.0101	CbGbCtD
Fentanyl—CYP3A4—Simvastatin—coronary artery disease	0.00297	0.00941	CbGbCtD
Fentanyl—CYP3A4—Pravastatin—coronary artery disease	0.0029	0.00921	CbGbCtD
Fentanyl—CYP3A4—Lovastatin—coronary artery disease	0.0029	0.00921	CbGbCtD
Fentanyl—CYP3A4—Atorvastatin—coronary artery disease	0.00264	0.00839	CbGbCtD
Fentanyl—CYP3A4—Losartan—coronary artery disease	0.00242	0.00767	CbGbCtD
Fentanyl—Cyclizine—SULT1E1—coronary artery disease	0.000435	0.18	CrCbGaD
Fentanyl—Remifentanil—OPRD1—coronary artery disease	0.000293	0.121	CrCbGaD
Fentanyl—Sufentanil—OPRD1—coronary artery disease	0.000261	0.108	CrCbGaD
Fentanyl—Diphenoxylate—OPRD1—coronary artery disease	0.000206	0.0855	CrCbGaD
Fentanyl—Loperamide—POMC—coronary artery disease	0.000152	0.0629	CrCbGaD
Fentanyl—Bepridil—ATP1A1—coronary artery disease	0.00015	0.0621	CrCbGaD
Fentanyl—Benazepril—MTHFR—coronary artery disease	0.000106	0.044	CrCbGaD
Fentanyl—Quinapril—ACE—coronary artery disease	9.95e-05	0.0412	CrCbGaD
Fentanyl—Dextropropoxyphene—OPRD1—coronary artery disease	8.98e-05	0.0372	CrCbGaD
Fentanyl—Benazepril—ACE—coronary artery disease	8.66e-05	0.0359	CrCbGaD
Fentanyl—Loperamide—OPRD1—coronary artery disease	8.56e-05	0.0354	CrCbGaD
Fentanyl—Phenoxybenzamine—SLC22A3—coronary artery disease	7.64e-05	0.0316	CrCbGaD
Fentanyl—Methadone—OPRD1—coronary artery disease	6.09e-05	0.0252	CrCbGaD
Fentanyl—Propafenone—ADRB1—coronary artery disease	5.98e-05	0.0248	CrCbGaD
Fentanyl—Alfentanil—ALB—coronary artery disease	5.38e-05	0.0223	CrCbGaD
Fentanyl—Benzatropine—CYP2C19—coronary artery disease	4.9e-05	0.0203	CrCbGaD
Fentanyl—Modafinil—CYP2C19—coronary artery disease	3.63e-05	0.015	CrCbGaD
Fentanyl—Phenoxybenzamine—ADRB2—coronary artery disease	3.49e-05	0.0145	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—coronary artery disease	2.89e-05	0.012	CrCbGaD
Fentanyl—Diphenhydramine—CYP2C19—coronary artery disease	2.52e-05	0.0104	CrCbGaD
Fentanyl—Methadone—CYP2C19—coronary artery disease	2.43e-05	0.0101	CrCbGaD
Fentanyl—Malaise—Lisinopril—coronary artery disease	1.95e-05	0.000149	CcSEcCtD
Fentanyl—Anaphylactic shock—Ramipril—coronary artery disease	1.95e-05	0.000148	CcSEcCtD
Fentanyl—Oedema—Ramipril—coronary artery disease	1.95e-05	0.000148	CcSEcCtD
Fentanyl—Vertigo—Lisinopril—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Dry mouth—Timolol—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Constipation—Losartan—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Pain—Losartan—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Syncope—Lisinopril—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Vomiting—Eplerenone—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Feeling abnormal—Furosemide—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Leukopenia—Lisinopril—coronary artery disease	1.94e-05	0.000148	CcSEcCtD
Fentanyl—Nausea—Fenofibrate—coronary artery disease	1.93e-05	0.000147	CcSEcCtD
Fentanyl—Pruritus—Niacin—coronary artery disease	1.93e-05	0.000147	CcSEcCtD
Fentanyl—Asthenia—Pravastatin—coronary artery disease	1.93e-05	0.000147	CcSEcCtD
Fentanyl—Gastrointestinal pain—Furosemide—coronary artery disease	1.92e-05	0.000147	CcSEcCtD
Fentanyl—Rash—Eplerenone—coronary artery disease	1.92e-05	0.000147	CcSEcCtD
Fentanyl—Urticaria—Perindopril—coronary artery disease	1.92e-05	0.000147	CcSEcCtD
Fentanyl—Hypersensitivity—Trandolapril—coronary artery disease	1.92e-05	0.000147	CcSEcCtD
Fentanyl—Dermatitis—Eplerenone—coronary artery disease	1.92e-05	0.000147	CcSEcCtD
Fentanyl—Diarrhoea—Valsartan—coronary artery disease	1.92e-05	0.000146	CcSEcCtD
Fentanyl—Confusional state—Timolol—coronary artery disease	1.92e-05	0.000146	CcSEcCtD
Fentanyl—Shock—Ramipril—coronary artery disease	1.92e-05	0.000146	CcSEcCtD
Fentanyl—Hypersensitivity—Enalapril—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Abdominal pain—Perindopril—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Body temperature increased—Perindopril—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Palpitations—Lisinopril—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Diarrhoea—Olmesartan—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Headache—Eplerenone—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Nervous system disorder—Ramipril—coronary artery disease	1.91e-05	0.000146	CcSEcCtD
Fentanyl—Thrombocytopenia—Ramipril—coronary artery disease	1.91e-05	0.000145	CcSEcCtD
Fentanyl—Anaphylactic shock—Timolol—coronary artery disease	1.9e-05	0.000145	CcSEcCtD
Fentanyl—Oedema—Timolol—coronary artery disease	1.9e-05	0.000145	CcSEcCtD
Fentanyl—Pruritus—Pravastatin—coronary artery disease	1.9e-05	0.000145	CcSEcCtD
Fentanyl—Loss of consciousness—Lisinopril—coronary artery disease	1.9e-05	0.000145	CcSEcCtD
Fentanyl—Nausea—Clopidogrel—coronary artery disease	1.9e-05	0.000145	CcSEcCtD
Fentanyl—Tachycardia—Ramipril—coronary artery disease	1.9e-05	0.000145	CcSEcCtD
Fentanyl—Skin disorder—Ramipril—coronary artery disease	1.89e-05	0.000144	CcSEcCtD
Fentanyl—Infection—Timolol—coronary artery disease	1.89e-05	0.000144	CcSEcCtD
Fentanyl—Vomiting—Simvastatin—coronary artery disease	1.89e-05	0.000144	CcSEcCtD
Fentanyl—Hypersensitivity—Telmisartan—coronary artery disease	1.89e-05	0.000144	CcSEcCtD
Fentanyl—Cough—Lisinopril—coronary artery disease	1.89e-05	0.000144	CcSEcCtD
Fentanyl—Nausea—Lovastatin—coronary artery disease	1.89e-05	0.000144	CcSEcCtD
Fentanyl—Hyperhidrosis—Ramipril—coronary artery disease	1.88e-05	0.000144	CcSEcCtD
Fentanyl—Rash—Simvastatin—coronary artery disease	1.87e-05	0.000143	CcSEcCtD
Fentanyl—Dermatitis—Simvastatin—coronary artery disease	1.87e-05	0.000143	CcSEcCtD
Fentanyl—Asthenia—Trandolapril—coronary artery disease	1.87e-05	0.000143	CcSEcCtD
Fentanyl—Shock—Timolol—coronary artery disease	1.87e-05	0.000143	CcSEcCtD
Fentanyl—Feeling abnormal—Losartan—coronary artery disease	1.87e-05	0.000143	CcSEcCtD
Fentanyl—Urticaria—Furosemide—coronary artery disease	1.87e-05	0.000143	CcSEcCtD
Fentanyl—Diarrhoea—Niacin—coronary artery disease	1.87e-05	0.000142	CcSEcCtD
Fentanyl—Nervous system disorder—Timolol—coronary artery disease	1.87e-05	0.000142	CcSEcCtD
Fentanyl—Asthenia—Enalapril—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Headache—Simvastatin—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Body temperature increased—Furosemide—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Abdominal pain—Furosemide—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Gastrointestinal pain—Losartan—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Dizziness—Valsartan—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Anorexia—Ramipril—coronary artery disease	1.86e-05	0.000142	CcSEcCtD
Fentanyl—Nausea—Ezetimibe—coronary artery disease	1.85e-05	0.000141	CcSEcCtD
Fentanyl—Skin disorder—Timolol—coronary artery disease	1.85e-05	0.000141	CcSEcCtD
Fentanyl—Dizziness—Olmesartan—coronary artery disease	1.85e-05	0.000141	CcSEcCtD
Fentanyl—Pruritus—Trandolapril—coronary artery disease	1.85e-05	0.000141	CcSEcCtD
Fentanyl—Myalgia—Lisinopril—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Arthralgia—Lisinopril—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Chest pain—Lisinopril—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Hyperhidrosis—Timolol—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Asthenia—Telmisartan—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Pruritus—Enalapril—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Diarrhoea—Pravastatin—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Anxiety—Lisinopril—coronary artery disease	1.84e-05	0.00014	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.83e-05	0.000139	CcSEcCtD
Fentanyl—Discomfort—Lisinopril—coronary artery disease	1.82e-05	0.000139	CcSEcCtD
Fentanyl—Hypotension—Ramipril—coronary artery disease	1.82e-05	0.000139	CcSEcCtD
Fentanyl—Anorexia—Timolol—coronary artery disease	1.81e-05	0.000138	CcSEcCtD
Fentanyl—Pruritus—Telmisartan—coronary artery disease	1.81e-05	0.000138	CcSEcCtD
Fentanyl—Nausea—Eplerenone—coronary artery disease	1.81e-05	0.000138	CcSEcCtD
Fentanyl—Dizziness—Niacin—coronary artery disease	1.8e-05	0.000138	CcSEcCtD
Fentanyl—Urticaria—Losartan—coronary artery disease	1.8e-05	0.000138	CcSEcCtD
Fentanyl—Dry mouth—Lisinopril—coronary artery disease	1.8e-05	0.000137	CcSEcCtD
Fentanyl—Abdominal pain—Losartan—coronary artery disease	1.79e-05	0.000137	CcSEcCtD
Fentanyl—Body temperature increased—Losartan—coronary artery disease	1.79e-05	0.000137	CcSEcCtD
Fentanyl—Asthenia—Captopril—coronary artery disease	1.79e-05	0.000136	CcSEcCtD
Fentanyl—Diarrhoea—Trandolapril—coronary artery disease	1.79e-05	0.000136	CcSEcCtD
Fentanyl—Vomiting—Valsartan—coronary artery disease	1.78e-05	0.000136	CcSEcCtD
Fentanyl—Confusional state—Lisinopril—coronary artery disease	1.78e-05	0.000136	CcSEcCtD
Fentanyl—Diarrhoea—Enalapril—coronary artery disease	1.78e-05	0.000136	CcSEcCtD
Fentanyl—Hypotension—Timolol—coronary artery disease	1.78e-05	0.000136	CcSEcCtD
Fentanyl—Dizziness—Pravastatin—coronary artery disease	1.78e-05	0.000136	CcSEcCtD
Fentanyl—Vomiting—Olmesartan—coronary artery disease	1.78e-05	0.000135	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.77e-05	0.000135	CcSEcCtD
Fentanyl—Rash—Valsartan—coronary artery disease	1.77e-05	0.000135	CcSEcCtD
Fentanyl—Dermatitis—Valsartan—coronary artery disease	1.77e-05	0.000135	CcSEcCtD
Fentanyl—Nausea—Simvastatin—coronary artery disease	1.77e-05	0.000135	CcSEcCtD
Fentanyl—Oedema—Lisinopril—coronary artery disease	1.77e-05	0.000135	CcSEcCtD
Fentanyl—Anaphylactic shock—Lisinopril—coronary artery disease	1.77e-05	0.000135	CcSEcCtD
Fentanyl—Pruritus—Captopril—coronary artery disease	1.76e-05	0.000135	CcSEcCtD
Fentanyl—Rash—Olmesartan—coronary artery disease	1.76e-05	0.000134	CcSEcCtD
Fentanyl—Insomnia—Ramipril—coronary artery disease	1.76e-05	0.000134	CcSEcCtD
Fentanyl—Dermatitis—Olmesartan—coronary artery disease	1.76e-05	0.000134	CcSEcCtD
Fentanyl—Headache—Valsartan—coronary artery disease	1.76e-05	0.000134	CcSEcCtD
Fentanyl—Diarrhoea—Telmisartan—coronary artery disease	1.75e-05	0.000134	CcSEcCtD
Fentanyl—Infection—Lisinopril—coronary artery disease	1.75e-05	0.000134	CcSEcCtD
Fentanyl—Headache—Olmesartan—coronary artery disease	1.75e-05	0.000133	CcSEcCtD
Fentanyl—Paraesthesia—Ramipril—coronary artery disease	1.75e-05	0.000133	CcSEcCtD
Fentanyl—Shock—Lisinopril—coronary artery disease	1.74e-05	0.000132	CcSEcCtD
Fentanyl—Asthenia—Perindopril—coronary artery disease	1.74e-05	0.000132	CcSEcCtD
Fentanyl—Dyspnoea—Ramipril—coronary artery disease	1.74e-05	0.000132	CcSEcCtD
Fentanyl—Vomiting—Niacin—coronary artery disease	1.74e-05	0.000132	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Timolol—coronary artery disease	1.73e-05	0.000132	CcSEcCtD
Fentanyl—Hypersensitivity—Furosemide—coronary artery disease	1.73e-05	0.000132	CcSEcCtD
Fentanyl—Somnolence—Ramipril—coronary artery disease	1.73e-05	0.000132	CcSEcCtD
Fentanyl—Thrombocytopenia—Lisinopril—coronary artery disease	1.73e-05	0.000132	CcSEcCtD
Fentanyl—Dizziness—Trandolapril—coronary artery disease	1.73e-05	0.000132	CcSEcCtD
Fentanyl—Tachycardia—Lisinopril—coronary artery disease	1.72e-05	0.000131	CcSEcCtD
Fentanyl—Insomnia—Timolol—coronary artery disease	1.72e-05	0.000131	CcSEcCtD
Fentanyl—Rash—Niacin—coronary artery disease	1.72e-05	0.000131	CcSEcCtD
Fentanyl—Dermatitis—Niacin—coronary artery disease	1.72e-05	0.000131	CcSEcCtD
Fentanyl—Dizziness—Enalapril—coronary artery disease	1.72e-05	0.000131	CcSEcCtD
Fentanyl—Skin disorder—Lisinopril—coronary artery disease	1.71e-05	0.000131	CcSEcCtD
Fentanyl—Dyspepsia—Ramipril—coronary artery disease	1.71e-05	0.000131	CcSEcCtD
Fentanyl—Pruritus—Perindopril—coronary artery disease	1.71e-05	0.000131	CcSEcCtD
Fentanyl—Headache—Niacin—coronary artery disease	1.71e-05	0.00013	CcSEcCtD
Fentanyl—Paraesthesia—Timolol—coronary artery disease	1.71e-05	0.00013	CcSEcCtD
Fentanyl—Vomiting—Pravastatin—coronary artery disease	1.71e-05	0.00013	CcSEcCtD
Fentanyl—Hyperhidrosis—Lisinopril—coronary artery disease	1.71e-05	0.00013	CcSEcCtD
Fentanyl—Diarrhoea—Captopril—coronary artery disease	1.71e-05	0.00013	CcSEcCtD
Fentanyl—Dyspnoea—Timolol—coronary artery disease	1.7e-05	0.000129	CcSEcCtD
Fentanyl—Dizziness—Telmisartan—coronary artery disease	1.7e-05	0.000129	CcSEcCtD
Fentanyl—Rash—Pravastatin—coronary artery disease	1.69e-05	0.000129	CcSEcCtD
Fentanyl—Dermatitis—Pravastatin—coronary artery disease	1.69e-05	0.000129	CcSEcCtD
Fentanyl—Decreased appetite—Ramipril—coronary artery disease	1.69e-05	0.000129	CcSEcCtD
Fentanyl—Somnolence—Timolol—coronary artery disease	1.69e-05	0.000129	CcSEcCtD
Fentanyl—Asthenia—Furosemide—coronary artery disease	1.69e-05	0.000129	CcSEcCtD
Fentanyl—Headache—Pravastatin—coronary artery disease	1.68e-05	0.000128	CcSEcCtD
Fentanyl—Anorexia—Lisinopril—coronary artery disease	1.68e-05	0.000128	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Ramipril—coronary artery disease	1.68e-05	0.000128	CcSEcCtD
Fentanyl—Fatigue—Ramipril—coronary artery disease	1.68e-05	0.000128	CcSEcCtD
Fentanyl—Dyspepsia—Timolol—coronary artery disease	1.68e-05	0.000128	CcSEcCtD
Fentanyl—Hypersensitivity—Losartan—coronary artery disease	1.67e-05	0.000128	CcSEcCtD
Fentanyl—Nausea—Valsartan—coronary artery disease	1.67e-05	0.000127	CcSEcCtD
Fentanyl—Pruritus—Furosemide—coronary artery disease	1.66e-05	0.000127	CcSEcCtD
Fentanyl—Constipation—Ramipril—coronary artery disease	1.66e-05	0.000127	CcSEcCtD
Fentanyl—Nausea—Olmesartan—coronary artery disease	1.66e-05	0.000127	CcSEcCtD
Fentanyl—Vomiting—Trandolapril—coronary artery disease	1.66e-05	0.000127	CcSEcCtD
Fentanyl—Diarrhoea—Perindopril—coronary artery disease	1.66e-05	0.000126	CcSEcCtD
Fentanyl—Decreased appetite—Timolol—coronary artery disease	1.65e-05	0.000126	CcSEcCtD
Fentanyl—Vomiting—Enalapril—coronary artery disease	1.65e-05	0.000126	CcSEcCtD
Fentanyl—Hypotension—Lisinopril—coronary artery disease	1.65e-05	0.000126	CcSEcCtD
Fentanyl—Dizziness—Captopril—coronary artery disease	1.65e-05	0.000126	CcSEcCtD
Fentanyl—Rash—Trandolapril—coronary artery disease	1.65e-05	0.000125	CcSEcCtD
Fentanyl—Dermatitis—Trandolapril—coronary artery disease	1.64e-05	0.000125	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Timolol—coronary artery disease	1.64e-05	0.000125	CcSEcCtD
Fentanyl—Fatigue—Timolol—coronary artery disease	1.64e-05	0.000125	CcSEcCtD
Fentanyl—Rash—Enalapril—coronary artery disease	1.64e-05	0.000125	CcSEcCtD
Fentanyl—Dermatitis—Enalapril—coronary artery disease	1.64e-05	0.000125	CcSEcCtD
Fentanyl—Headache—Trandolapril—coronary artery disease	1.63e-05	0.000125	CcSEcCtD
Fentanyl—Vomiting—Telmisartan—coronary artery disease	1.63e-05	0.000124	CcSEcCtD
Fentanyl—Asthenia—Losartan—coronary artery disease	1.63e-05	0.000124	CcSEcCtD
Fentanyl—Headache—Enalapril—coronary artery disease	1.63e-05	0.000124	CcSEcCtD
Fentanyl—Pain—Timolol—coronary artery disease	1.63e-05	0.000124	CcSEcCtD
Fentanyl—Nausea—Niacin—coronary artery disease	1.62e-05	0.000124	CcSEcCtD
Fentanyl—Rash—Telmisartan—coronary artery disease	1.62e-05	0.000123	CcSEcCtD
Fentanyl—Dermatitis—Telmisartan—coronary artery disease	1.61e-05	0.000123	CcSEcCtD
Fentanyl—Diarrhoea—Furosemide—coronary artery disease	1.61e-05	0.000123	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.61e-05	0.000123	CcSEcCtD
Fentanyl—Pruritus—Losartan—coronary artery disease	1.61e-05	0.000122	CcSEcCtD
Fentanyl—Headache—Telmisartan—coronary artery disease	1.61e-05	0.000122	CcSEcCtD
Fentanyl—Feeling abnormal—Ramipril—coronary artery disease	1.6e-05	0.000122	CcSEcCtD
Fentanyl—Dizziness—Perindopril—coronary artery disease	1.6e-05	0.000122	CcSEcCtD
Fentanyl—Insomnia—Lisinopril—coronary artery disease	1.6e-05	0.000122	CcSEcCtD
Fentanyl—Nausea—Pravastatin—coronary artery disease	1.6e-05	0.000122	CcSEcCtD
Fentanyl—Gastrointestinal pain—Ramipril—coronary artery disease	1.59e-05	0.000121	CcSEcCtD
Fentanyl—Paraesthesia—Lisinopril—coronary artery disease	1.59e-05	0.000121	CcSEcCtD
Fentanyl—Vomiting—Captopril—coronary artery disease	1.58e-05	0.000121	CcSEcCtD
Fentanyl—Dyspnoea—Lisinopril—coronary artery disease	1.57e-05	0.00012	CcSEcCtD
Fentanyl—Rash—Captopril—coronary artery disease	1.57e-05	0.00012	CcSEcCtD
Fentanyl—Dermatitis—Captopril—coronary artery disease	1.57e-05	0.00012	CcSEcCtD
Fentanyl—Somnolence—Lisinopril—coronary artery disease	1.57e-05	0.00012	CcSEcCtD
Fentanyl—Feeling abnormal—Timolol—coronary artery disease	1.57e-05	0.00012	CcSEcCtD
Fentanyl—Headache—Captopril—coronary artery disease	1.56e-05	0.000119	CcSEcCtD
Fentanyl—Gastrointestinal pain—Timolol—coronary artery disease	1.56e-05	0.000119	CcSEcCtD
Fentanyl—Dizziness—Furosemide—coronary artery disease	1.56e-05	0.000119	CcSEcCtD
Fentanyl—Dyspepsia—Lisinopril—coronary artery disease	1.55e-05	0.000119	CcSEcCtD
Fentanyl—Diarrhoea—Losartan—coronary artery disease	1.55e-05	0.000118	CcSEcCtD
Fentanyl—Nausea—Trandolapril—coronary artery disease	1.55e-05	0.000118	CcSEcCtD
Fentanyl—Urticaria—Ramipril—coronary artery disease	1.55e-05	0.000118	CcSEcCtD
Fentanyl—Nausea—Enalapril—coronary artery disease	1.54e-05	0.000118	CcSEcCtD
Fentanyl—Vomiting—Perindopril—coronary artery disease	1.54e-05	0.000117	CcSEcCtD
Fentanyl—Body temperature increased—Ramipril—coronary artery disease	1.54e-05	0.000117	CcSEcCtD
Fentanyl—Abdominal pain—Ramipril—coronary artery disease	1.54e-05	0.000117	CcSEcCtD
Fentanyl—Decreased appetite—Lisinopril—coronary artery disease	1.53e-05	0.000117	CcSEcCtD
Fentanyl—Rash—Perindopril—coronary artery disease	1.53e-05	0.000116	CcSEcCtD
Fentanyl—Dermatitis—Perindopril—coronary artery disease	1.52e-05	0.000116	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.52e-05	0.000116	CcSEcCtD
Fentanyl—Nausea—Telmisartan—coronary artery disease	1.52e-05	0.000116	CcSEcCtD
Fentanyl—Fatigue—Lisinopril—coronary artery disease	1.52e-05	0.000116	CcSEcCtD
Fentanyl—Headache—Perindopril—coronary artery disease	1.52e-05	0.000116	CcSEcCtD
Fentanyl—Urticaria—Timolol—coronary artery disease	1.51e-05	0.000115	CcSEcCtD
Fentanyl—Pain—Lisinopril—coronary artery disease	1.51e-05	0.000115	CcSEcCtD
Fentanyl—Constipation—Lisinopril—coronary artery disease	1.51e-05	0.000115	CcSEcCtD
Fentanyl—Abdominal pain—Timolol—coronary artery disease	1.5e-05	0.000115	CcSEcCtD
Fentanyl—Body temperature increased—Timolol—coronary artery disease	1.5e-05	0.000115	CcSEcCtD
Fentanyl—Dizziness—Losartan—coronary artery disease	1.5e-05	0.000114	CcSEcCtD
Fentanyl—Vomiting—Furosemide—coronary artery disease	1.5e-05	0.000114	CcSEcCtD
Fentanyl—Rash—Furosemide—coronary artery disease	1.48e-05	0.000113	CcSEcCtD
Fentanyl—Dermatitis—Furosemide—coronary artery disease	1.48e-05	0.000113	CcSEcCtD
Fentanyl—Nausea—Captopril—coronary artery disease	1.48e-05	0.000113	CcSEcCtD
Fentanyl—Headache—Furosemide—coronary artery disease	1.47e-05	0.000112	CcSEcCtD
Fentanyl—Feeling abnormal—Lisinopril—coronary artery disease	1.45e-05	0.000111	CcSEcCtD
Fentanyl—Gastrointestinal pain—Lisinopril—coronary artery disease	1.44e-05	0.00011	CcSEcCtD
Fentanyl—Vomiting—Losartan—coronary artery disease	1.44e-05	0.00011	CcSEcCtD
Fentanyl—Nausea—Perindopril—coronary artery disease	1.44e-05	0.00011	CcSEcCtD
Fentanyl—Hypersensitivity—Ramipril—coronary artery disease	1.43e-05	0.000109	CcSEcCtD
Fentanyl—Rash—Losartan—coronary artery disease	1.43e-05	0.000109	CcSEcCtD
Fentanyl—Dermatitis—Losartan—coronary artery disease	1.43e-05	0.000109	CcSEcCtD
Fentanyl—Headache—Losartan—coronary artery disease	1.42e-05	0.000108	CcSEcCtD
Fentanyl—Urticaria—Lisinopril—coronary artery disease	1.4e-05	0.000107	CcSEcCtD
Fentanyl—Hypersensitivity—Timolol—coronary artery disease	1.4e-05	0.000107	CcSEcCtD
Fentanyl—Nausea—Furosemide—coronary artery disease	1.4e-05	0.000107	CcSEcCtD
Fentanyl—Asthenia—Ramipril—coronary artery disease	1.4e-05	0.000107	CcSEcCtD
Fentanyl—Body temperature increased—Lisinopril—coronary artery disease	1.4e-05	0.000106	CcSEcCtD
Fentanyl—Abdominal pain—Lisinopril—coronary artery disease	1.4e-05	0.000106	CcSEcCtD
Fentanyl—Pruritus—Ramipril—coronary artery disease	1.38e-05	0.000105	CcSEcCtD
Fentanyl—Asthenia—Timolol—coronary artery disease	1.37e-05	0.000104	CcSEcCtD
Fentanyl—Nausea—Losartan—coronary artery disease	1.35e-05	0.000103	CcSEcCtD
Fentanyl—Pruritus—Timolol—coronary artery disease	1.35e-05	0.000103	CcSEcCtD
Fentanyl—Diarrhoea—Ramipril—coronary artery disease	1.33e-05	0.000102	CcSEcCtD
Fentanyl—Diarrhoea—Timolol—coronary artery disease	1.3e-05	9.93e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Lisinopril—coronary artery disease	1.3e-05	9.92e-05	CcSEcCtD
Fentanyl—Dizziness—Ramipril—coronary artery disease	1.29e-05	9.82e-05	CcSEcCtD
Fentanyl—Asthenia—Lisinopril—coronary artery disease	1.27e-05	9.66e-05	CcSEcCtD
Fentanyl—Dizziness—Timolol—coronary artery disease	1.26e-05	9.6e-05	CcSEcCtD
Fentanyl—Pruritus—Lisinopril—coronary artery disease	1.25e-05	9.53e-05	CcSEcCtD
Fentanyl—Vomiting—Ramipril—coronary artery disease	1.24e-05	9.44e-05	CcSEcCtD
Fentanyl—Rash—Ramipril—coronary artery disease	1.23e-05	9.36e-05	CcSEcCtD
Fentanyl—Dermatitis—Ramipril—coronary artery disease	1.23e-05	9.35e-05	CcSEcCtD
Fentanyl—Headache—Ramipril—coronary artery disease	1.22e-05	9.3e-05	CcSEcCtD
Fentanyl—Vomiting—Timolol—coronary artery disease	1.21e-05	9.23e-05	CcSEcCtD
Fentanyl—Diarrhoea—Lisinopril—coronary artery disease	1.21e-05	9.21e-05	CcSEcCtD
Fentanyl—Rash—Timolol—coronary artery disease	1.2e-05	9.15e-05	CcSEcCtD
Fentanyl—Dermatitis—Timolol—coronary artery disease	1.2e-05	9.14e-05	CcSEcCtD
Fentanyl—Headache—Timolol—coronary artery disease	1.19e-05	9.09e-05	CcSEcCtD
Fentanyl—Dizziness—Lisinopril—coronary artery disease	1.17e-05	8.9e-05	CcSEcCtD
Fentanyl—Nausea—Ramipril—coronary artery disease	1.16e-05	8.82e-05	CcSEcCtD
Fentanyl—Nausea—Timolol—coronary artery disease	1.13e-05	8.62e-05	CcSEcCtD
Fentanyl—Vomiting—Lisinopril—coronary artery disease	1.12e-05	8.56e-05	CcSEcCtD
Fentanyl—Rash—Lisinopril—coronary artery disease	1.11e-05	8.49e-05	CcSEcCtD
Fentanyl—Dermatitis—Lisinopril—coronary artery disease	1.11e-05	8.48e-05	CcSEcCtD
Fentanyl—Headache—Lisinopril—coronary artery disease	1.11e-05	8.43e-05	CcSEcCtD
Fentanyl—Nausea—Lisinopril—coronary artery disease	1.05e-05	8e-05	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—CCL2—coronary artery disease	3.46e-06	7.9e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6R—coronary artery disease	3.45e-06	7.88e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCA1—coronary artery disease	3.45e-06	7.87e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ESR1—coronary artery disease	3.44e-06	7.87e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALDH2—coronary artery disease	3.43e-06	7.84e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	3.43e-06	7.84e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.42e-06	7.82e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HK2—coronary artery disease	3.42e-06	7.82e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	3.41e-06	7.8e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FN1—coronary artery disease	3.4e-06	7.77e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—F2—coronary artery disease	3.4e-06	7.77e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—coronary artery disease	3.4e-06	7.77e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	3.39e-06	7.74e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	3.38e-06	7.73e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—coronary artery disease	3.37e-06	7.69e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	3.36e-06	7.68e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	3.35e-06	7.66e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LIPC—coronary artery disease	3.34e-06	7.64e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HBA1—coronary artery disease	3.34e-06	7.64e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.34e-06	7.64e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.34e-06	7.64e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GOT1—coronary artery disease	3.34e-06	7.62e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GGT1—coronary artery disease	3.34e-06	7.62e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOC3—coronary artery disease	3.32e-06	7.59e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LDLR—coronary artery disease	3.3e-06	7.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.28e-06	7.49e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	3.28e-06	7.49e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—C3—coronary artery disease	3.27e-06	7.48e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.26e-06	7.46e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—coronary artery disease	3.26e-06	7.46e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KIT—coronary artery disease	3.26e-06	7.44e-05	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.23e-06	7.39e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	3.23e-06	7.37e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCLC—coronary artery disease	3.23e-06	7.37e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CETP—coronary artery disease	3.23e-06	7.37e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LCAT—coronary artery disease	3.22e-06	7.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.22e-06	7.35e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AGT—coronary artery disease	3.2e-06	7.31e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SDC1—coronary artery disease	3.19e-06	7.29e-05	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.17e-06	7.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA4—coronary artery disease	3.16e-06	7.21e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOE—coronary artery disease	3.14e-06	7.16e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGF2—coronary artery disease	3.12e-06	7.14e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	3.12e-06	7.14e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	3.12e-06	7.13e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AGT—coronary artery disease	3.11e-06	7.11e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOA1—coronary artery disease	3.1e-06	7.08e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—coronary artery disease	3.1e-06	7.08e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CREB1—coronary artery disease	3.1e-06	7.08e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—coronary artery disease	3.08e-06	7.04e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.05e-06	6.97e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCLM—coronary artery disease	3.05e-06	6.97e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOE—coronary artery disease	3.05e-06	6.96e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—coronary artery disease	3.05e-06	6.96e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL2—coronary artery disease	3.03e-06	6.93e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6R—coronary artery disease	3.02e-06	6.91e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOA1—coronary artery disease	3.01e-06	6.89e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMA6—coronary artery disease	3.01e-06	6.88e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMB5—coronary artery disease	3.01e-06	6.88e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—coronary artery disease	3e-06	6.85e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JAK2—coronary artery disease	3e-06	6.84e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—coronary artery disease	2.99e-06	6.82e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—coronary artery disease	2.98e-06	6.81e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	2.97e-06	6.79e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	2.97e-06	6.78e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	2.97e-06	6.78e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—coronary artery disease	2.96e-06	6.75e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.95e-06	6.75e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.95e-06	6.75e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CTGF—coronary artery disease	2.94e-06	6.73e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	2.94e-06	6.71e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GOT2—coronary artery disease	2.92e-06	6.67e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMGCR—coronary artery disease	2.92e-06	6.67e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAT—coronary artery disease	2.92e-06	6.66e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—coronary artery disease	2.91e-06	6.65e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.91e-06	6.65e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—F2—coronary artery disease	2.87e-06	6.57e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FN1—coronary artery disease	2.87e-06	6.57e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.87e-06	6.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HADH—coronary artery disease	2.87e-06	6.55e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	2.86e-06	6.54e-05	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.86e-06	6.53e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	2.84e-06	6.49e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.83e-06	6.48e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOB—coronary artery disease	2.83e-06	6.47e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	2.83e-06	6.47e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—coronary artery disease	2.75e-06	6.29e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIT—coronary artery disease	2.75e-06	6.29e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGF2—coronary artery disease	2.74e-06	6.26e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	2.73e-06	6.25e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—coronary artery disease	2.73e-06	6.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.72e-06	6.21e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX2—coronary artery disease	2.72e-06	6.21e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA2—coronary artery disease	2.72e-06	6.21e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LPL—coronary artery disease	2.7e-06	6.18e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—coronary artery disease	2.7e-06	6.17e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—coronary artery disease	2.69e-06	6.15e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX4—coronary artery disease	2.68e-06	6.13e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.68e-06	6.13e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.68e-06	6.13e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HK1—coronary artery disease	2.68e-06	6.13e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLCB1—coronary artery disease	2.68e-06	6.13e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HADHA—coronary artery disease	2.65e-06	6.06e-05	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	2.64e-06	6.03e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	2.64e-06	6.03e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX1—coronary artery disease	2.64e-06	6.03e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JAK2—coronary artery disease	2.63e-06	6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.62e-06	5.99e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—coronary artery disease	2.62e-06	5.98e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CREB1—coronary artery disease	2.62e-06	5.98e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—coronary artery disease	2.62e-06	5.98e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ABCA1—coronary artery disease	2.6e-06	5.94e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—coronary artery disease	2.6e-06	5.94e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPA—coronary artery disease	2.59e-06	5.92e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	2.57e-06	5.88e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CD36—coronary artery disease	2.57e-06	5.87e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL2—coronary artery disease	2.56e-06	5.85e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6R—coronary artery disease	2.55e-06	5.84e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—coronary artery disease	2.55e-06	5.82e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPP2CA—coronary artery disease	2.54e-06	5.8e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—coronary artery disease	2.52e-06	5.76e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GOT1—coronary artery disease	2.52e-06	5.75e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GGT1—coronary artery disease	2.52e-06	5.75e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.51e-06	5.74e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.51e-06	5.73e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA5—coronary artery disease	2.49e-06	5.68e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—coronary artery disease	2.47e-06	5.65e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—coronary artery disease	2.46e-06	5.61e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—P4HB—coronary artery disease	2.44e-06	5.57e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—coronary artery disease	2.43e-06	5.56e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	2.4e-06	5.48e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	2.4e-06	5.48e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.4e-06	5.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.39e-06	5.47e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.39e-06	5.47e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—coronary artery disease	2.35e-06	5.37e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGF2—coronary artery disease	2.32e-06	5.29e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	2.32e-06	5.29e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AGT—coronary artery disease	2.31e-06	5.29e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—coronary artery disease	2.29e-06	5.24e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—coronary artery disease	2.28e-06	5.22e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—coronary artery disease	2.28e-06	5.21e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOE—coronary artery disease	2.27e-06	5.18e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—coronary artery disease	2.26e-06	5.17e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—VCAN—coronary artery disease	2.26e-06	5.15e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.24e-06	5.12e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOA1—coronary artery disease	2.24e-06	5.12e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.24e-06	5.11e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—coronary artery disease	2.23e-06	5.1e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—coronary artery disease	2.23e-06	5.1e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	2.22e-06	5.07e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JAK2—coronary artery disease	2.22e-06	5.07e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAT—coronary artery disease	2.2e-06	5.03e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.18e-06	4.97e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DCN—coronary artery disease	2.17e-06	4.96e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—coronary artery disease	2.17e-06	4.95e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.15e-06	4.91e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOB—coronary artery disease	2.14e-06	4.88e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.11e-06	4.83e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	2.1e-06	4.8e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—coronary artery disease	2.08e-06	4.75e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LIPC—coronary artery disease	2.06e-06	4.71e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HBA1—coronary artery disease	2.06e-06	4.71e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.06e-06	4.71e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.06e-06	4.71e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOC3—coronary artery disease	2.05e-06	4.68e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPL—coronary artery disease	2.04e-06	4.66e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	2.04e-06	4.66e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LDLR—coronary artery disease	2.03e-06	4.65e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	2.03e-06	4.63e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.01e-06	4.59e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.01e-06	4.59e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	2e-06	4.57e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX1—coronary artery disease	1.99e-06	4.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCLC—coronary artery disease	1.99e-06	4.54e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CETP—coronary artery disease	1.99e-06	4.54e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—coronary artery disease	1.97e-06	4.51e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SDC1—coronary artery disease	1.97e-06	4.49e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.96e-06	4.47e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—coronary artery disease	1.95e-06	4.45e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	1.95e-06	4.45e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—coronary artery disease	1.94e-06	4.43e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CD36—coronary artery disease	1.94e-06	4.43e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—coronary artery disease	1.93e-06	4.4e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.91e-06	4.37e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—coronary artery disease	1.89e-06	4.31e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.86e-06	4.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.86e-06	4.24e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—coronary artery disease	1.84e-06	4.2e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—coronary artery disease	1.83e-06	4.19e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CTGF—coronary artery disease	1.81e-06	4.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.8e-06	4.11e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GOT2—coronary artery disease	1.8e-06	4.11e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	1.79e-06	4.08e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	1.78e-06	4.06e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—coronary artery disease	1.78e-06	4.06e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	1.75e-06	4e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AGT—coronary artery disease	1.75e-06	3.99e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.73e-06	3.96e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOE—coronary artery disease	1.71e-06	3.91e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—coronary artery disease	1.7e-06	3.88e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA1—coronary artery disease	1.69e-06	3.86e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.65e-06	3.78e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	1.65e-06	3.76e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.6e-06	3.66e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.55e-06	3.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GGT1—coronary artery disease	1.55e-06	3.54e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GOT1—coronary artery disease	1.55e-06	3.54e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—coronary artery disease	1.54e-06	3.51e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	1.52e-06	3.47e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	1.51e-06	3.45e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—coronary artery disease	1.49e-06	3.4e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	1.48e-06	3.38e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—coronary artery disease	1.47e-06	3.36e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—coronary artery disease	1.42e-06	3.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.39e-06	3.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.38e-06	3.15e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.37e-06	3.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAT—coronary artery disease	1.36e-06	3.1e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—coronary artery disease	1.35e-06	3.08e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—coronary artery disease	1.34e-06	3.06e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.32e-06	3.02e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOB—coronary artery disease	1.32e-06	3.01e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.29e-06	2.94e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—coronary artery disease	1.28e-06	2.93e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.28e-06	2.93e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPL—coronary artery disease	1.26e-06	2.87e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—coronary artery disease	1.24e-06	2.84e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX1—coronary artery disease	1.23e-06	2.8e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CD36—coronary artery disease	1.19e-06	2.73e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.18e-06	2.69e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—coronary artery disease	1.17e-06	2.68e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—coronary artery disease	1.14e-06	2.6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.13e-06	2.59e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—coronary artery disease	1.08e-06	2.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AGT—coronary artery disease	1.08e-06	2.46e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOE—coronary artery disease	1.05e-06	2.41e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—coronary artery disease	1.05e-06	2.4e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA1—coronary artery disease	1.04e-06	2.38e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—coronary artery disease	9.56e-07	2.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—coronary artery disease	9.18e-07	2.1e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—coronary artery disease	9.05e-07	2.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—coronary artery disease	8.25e-07	1.89e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—coronary artery disease	7.89e-07	1.8e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—coronary artery disease	7.81e-07	1.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.22e-07	1.65e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.21e-07	1.65e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—coronary artery disease	5.89e-07	1.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.44e-07	1.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—coronary artery disease	3.63e-07	8.29e-06	CbGpPWpGaD
